The GLP is committed to full transparency. Download and review our Annual Report.

The GLP is committed to full transparency. Download and review our Annual Report.

Dicamba controversy: EPA’s decision on herbicide’s future expected by end of September

| | August 30, 2018

Throughout this year, EPA has been monitoring reports during the application season and it’s expected the agency will announce its decision for the future of …. dicamba products by the end of September.

For review… in 2016, EPA registered the new dicamba formulations for over-the-top use (Engenia, FeXapan and Xtendimax). When the new products were registered, the EPA set the regulations to automatically expire in two years, which would allow the EPA to review and change the registration if necessary.

According to Monsanto, the company has received 381 calls and has visited 299 of those farms with complaints as of July 12. As of July 15, Kevin Bradley at the University of Missouri assembled 605 dicamba-related injury investigations from state departments of agriculture.

Related article:  Viewpoint: Scott Pruitt gone from EPA because of ethical transgressions but regulatory reform of 'rogue agency' might be his lasting legacy

The Illinois Fertilizer and Chemical Association received survey responses from more than 110 professional applicators about their experience with dicamba in 2018.  As of mid-August, the Illinois Department of Agriculture has received 319 misuse complaints attributed to dicamba symptoms (the total number of pesticide misuse complaints so far in 2018 totals 500, which is a historic high.) Those survey responses (in addition to their ongoing conversations with stakeholders) led to the IFCA sending four recommendations to the EPA for their consideration in weighing their decision for dicamba’s future.

So for now, we wait.

Read full, original article: Waiting For Dicamba’s Second Shoe to Drop

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend